{"filing":{"accession_number":"0001213900-26-076526","cik":"0001681682","ticker":"NDRA","company_name":"ENDRA Life Sciences Inc.","form":"8-K","filing_date":"2026-07-09","report_date":null,"primary_document":"ea0297455-8k_endra.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026076526/ea0297455-8k_endra.htm"},"events":[{"id":17217,"run_id":15403,"accession_number":"0001213900-26-076526","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The filing discloses that ENDRA regained compliance with Nasdaq's Minimum Stockholders' Equity Requirement (Nasdaq Listing Rule 5550(b)(1)) after initially falling below the $2,500,000 threshold. However, the company is now subject to a one-year Discretionary Panel Monitor period, during which any future non-compliance with Nasdaq Listing Rules will result in immediate delisting without opportunity for a cure period or compliance plan. This represents a material delisting risk that would significantly affect investor assessment of the registrant's continued listing status.","company_name":"ENDRA Life Sciences Inc.","ticker":"NDRA","filing_date":"2026-07-09","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":15588,"accession_number":"0001213900-26-076526","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that ENDRA regained compliance with Nasdaq's Minimum Stockholders' Equity Requirement (Nasdaq Listing Rule 5550(b)(1)) after initially falling below the $2,500,000 threshold. However, the company is now subject to a one-year Discretionary Panel Monitor period, during which any future non-compliance with Nasdaq Listing Rules will result in immediate delisting without opportunity for a cure period or compliance plan. This represents a material delisting risk that would significantly affect investor assessment of the registrant's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T13:05:16.811521+00:00","company_name":"ENDRA Life Sciences Inc.","ticker":"NDRA","filing_date":"2026-07-09"}]}